Compositions with hematopoietic and immune activity

Details Compositions with hematopoietic and immune activity Compositions with hematopoietic and immune activity

2004-03-12

2009-12-15

Gamett, Daniel C (Department: 1647)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C424S278100, C424S192100

Reexamination Certificate

active

07632810

ABSTRACT:
The present invention provides methods of using Bv8 and EG-VEGF polypeptides and nucleic acids to promote hemtopoiesis. Also provided herein are methods of screening for modulators of Bv8 and EG-VEGF activity. Furthermore, methods of treatment using Bv8 and EG-VEGF polypeptides or Bv8 and EG-VEGF antagonists are provided.

REFERENCES:
patent: 5240848 (1993-08-01), Keck et al.
patent: 5332671 (1994-07-01), Ferrara et al.
patent: 6020473 (2000-02-01), Keyt et al.
patent: 6485938 (2002-11-01), Sheppard et al.
patent: 7060278 (2006-06-01), Ferrara et al.
patent: 7264801 (2007-09-01), Ferrara et al.
patent: 2002/0115610 (2002-08-01), Zhou et al.
patent: 2003/0027998 (2003-02-01), Holtzman et al.
patent: 2003/0171306 (2003-09-01), Davis et al.
patent: WO 97/08313 (1997-03-01), None
patent: WO 98/10071 (1998-03-01), None
patent: WO 99/06550 (1999-02-01), None
patent: WO 99/63088 (1999-12-01), None
patent: WO 00/52022 (2000-09-01), None
patent: WO 00/53753 (2000-09-01), None
patent: WO 00/63380 (2000-10-01), None
patent: WO 00/70049 (2000-11-01), None
patent: WO 00/73454 (2000-12-01), None
patent: WO 00/75327 (2000-12-01), None
patent: WO 01/36465 (2001-05-01), None
patent: WO 01/40466 (2001-06-01), None
patent: WO 01/93983 (2001-12-01), None
patent: 02/00711 (2002-01-01), None
patent: WO 02/00690 (2002-01-01), None
patent: WO 02/00711 (2002-01-01), None
patent: WO 02/08284 (2002-01-01), None
patent: WO 02/08288 (2002-01-01), None
patent: WO 02/36625 (2002-05-01), None
patent: 03/020892 (2003-03-01), None
patent: WO 03/020892 (2003-03-01), None
Ju et al. (Proc Nat'l Acad Sci U S A. Apr. 1, 1991;88(7):2658-62).
Kruse et al. (EMBO J. Sep. 1992;11(9):3237-44).
LeCouter et al. “Endocrine gland-derived VEGF and the emerging hypothesis of organ-specific regulation of angiogenesis” Nature Medicine, vol. 8, No. 9, Sep. 2002 pp. 913-917.
Wechselberger et al. “The mammalian homologues of frog Bv8 are mainly expressed in spermatocytes” FEBS Letters, vol. 462, No. 1-2, Nov. 26, 1999, pp. 177-181.
LeCouter et al. “Identification of an angiogenic mitogen selective for endocrine gland endothelium” Nature, vol. 412, No. 6850, Aug. 30, 2001, pp. 877-884.
Gerber and Ferrara, 2003,J. mol. Med., 81:20-31 “The role of VEGF in normal and neoplastic hematopoiesis.”
Janowska-Wieczorek et al., 2001,Stem Cells, 19:99-107 “Autocrine/Paracrine Mechanisms in Human Hematopoiesis.”
LeCouter et al., 2003,Proc. Natl. Acd. Sci. USA, 100:2685-2690 “The endocrine-gland-derived VEGF homologue Bv8 promotes angiogenesis in the testis: Localization of Bv8 receptors to endothelial cells.”
Leung et al., 1989,Science, 246:1306-1309 “Vascular Endothelial Growth Factor is a Secreted Anigogenic Mitogen.”
Lin et al., 2002,J. Biol. Chem., 277:19276-19280.
Masuda et al., 2002,Biochem. Biophsy. Res. Commun., 293:396-402.“Isolation and identification of EG-VEGF/prokineticins ascognate ligands for two orphan G-protein-coupled receptors.”
Mollay et al., 1999,Eur. J. Pharamcol., 374:189-196 “Bv8, a small protein from frog skin and its homologue from snake venom induce hyperalgesia in rats.”
Zhou et al., 2001,Mol. Pharmacol., 59:692-698 “Identification of Two Prokineticin cDNAs: Recombinant Proteins Potently Contract Gastrointestinal Smooth Muscle.”
Kaser et al., 2003,EMBO Reports, 4:469-473.
Kisliouk et al., 2005,Endocrinology, 146:3950-3958.
LeCouter et al., 2003,Endocrinology, 144:2606-2616.
Li et al., 2001,Mol. Pharmacol., 59:692-698.
Negri et al., 2005,Brit. J. Pharmacol., 146:625-632.

Affiliated with

Also associated with

Rating

Compositions with hematopoietic and immune activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions with hematopoietic and immune activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions with hematopoietic and immune activity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4122490